| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Korean Journal of Otorhinolaryngology-Head and Neck Surgery > Volume 33(5); 1990 > Article
Korean Journal of Otorhinolaryngology-Head and Neck Surgery 1990;33(5): 937-44.
Regional Intra-Arterial Chemotherapy of Head and Neck Cancer
Youn Sang Shim, MD1, Kyung Kyoon Oh, MD1, Yong Sik Lee, MD1, Young Chang Han, MD1, Moo Jin Choo, MD1, and Hong Sik Byun, MD2
1;Department of Otolaryngology-Head and Neck Surgery, 2;Diagnostic Radiology, Korea Cancer Center Hospital, Korea
두경부 악성종양에서의 국소동맥내 항암화학요법
심윤상1 · 오경균1 · 이용식1 · 한영창1 · 추무진1 · 변홍식2
원자력병원 이비인후과1;진단방사선과2;
ABSTRACT

Regional intra-arterial chemotherapy has the potential advantages of delivering a higher concentration of effective chemotherapeutic agents to the tumor site while minimizing systemic toxic reactions. Seventeen patients with head and neck cancer were treated with combined regional intra-arterial and systemic chemotherapy. Total 29 cycles were performed at the Department of Otolaryngology-Head and Neck Surgery, Korea Cancer Center Hospital from Sept. 1988 to Sept. 1989. The results were as follows ; 1) Immediate overall response rate(CR+PR) was 88.3%. 2) Relatively high response rate was obtained in the patients with tonsil cancer or maxillary cancer. 3) Side effects were similar to the systemic chemotherapy. But ipsilateral alopecia, high tone hearing loss, the swelling of the face and neck, and facial nerve palsy were characteristic in the regional intra-arterial chemotherapy. 4) In the cases of the palliative chemotherapy, patients were improved in the symptoms that were local pain and/or odynophagia.

Keywords: Intra-arterial chemotherapyHead and neck cancer.
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Share:      
METRICS
1,105
View
6
Download
Related articles
Drug Repositioning for Treatment of Head and Neck Cancers  2023 August;66(8)
Treatment for Locoregionally Recurrent Head and Neck Cancers  2022 March;65(3)
The Role of MicroRNA in Head and Neck Cancer  2022 February;65(2)
Targeting Fatty Acid Metabolism in Head and Neck Cancer  2021 June;64(6)
Radioimmunotherapy in Head and Neck Cancer  2018 December;61(12)
Editorial Office
Korean Society of Otorhinolaryngology-Head and Neck Surgery
103-307 67 Seobinggo-ro, Yongsan-gu, Seoul 04385, Korea
TEL: +82-2-3487-6602    FAX: +82-2-3487-6603   E-mail: kjorl@korl.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © Korean Society of Otorhinolaryngology-Head and Neck Surgery.                 Developed in M2PI
Close layer
prev next